GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
K

Knight Therapeutics GUD.TO · CAD

Health Care · Toronto Stock Exchange · 🇨🇦 Canada

Compare

11.60

+1.58%

Close of 9 Nov 2026, in CAD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Popular Bitcoin Ethereum Nvidia Apple S&P 500 Gold EUR/USD US 10Y

At a glance

Figures in CAD, from our data supplier.

FY2024

Revenue

C$371.3m

FY2015FY2024

Net income

C$4.3m

FY2015FY2024

Free cash flow

C$4.8m

FY2015FY2024

Shareholders' equity

C$795.1m

FY2015FY2024

Income statement

Fiscal years

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
RevenueC$371.3mC$328.2mC$293.6mC$243.5mC$199.5mC$47.5mC$12.5mC$8.6mC$5.9mC$1.0m
Research and developmentC$23.3mC$17.5mC$14.8mC$12.7mC$11.7mC$3.9mC$2.0mC$2.8mC$2.0mC$2.7m
Operating incomeC$7.4mC$6.4m−C$17.1m−C$12.8m−C$26.3m−C$4.7m−C$5.8m−C$8.9m−C$3.9m−C$9.1m
Net incomeC$4.3m−C$16.8m−C$29.9mC$15.7mC$42.1mC$14.5mC$24.1mC$17.2mC$18.6mC$34.2m
Diluted earnings per share0.04-0.16-0.260.130.320.100.170.120.150.35

Balance sheet

At each fiscal year end

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Total assetsC$963.8mC$945.5mC$1.05bnC$991.9mC$1.04bnC$1.31bnC$1.05bnC$1.01bnC$990.8mC$649.0m
Cash and short-term investmentsC$163.1mC$157.8mC$191.0mC$162.7mC$411.2mC$427.7mC$703.8mC$787.9mC$787.8mC$494.8m
Total liabilitiesC$168.7mC$198.6mC$229.0mC$149.9mC$153.4mC$494.6mC$21.8mC$14.8mC$11.1mC$6.9m
DebtC$49.5mC$69.1mC$77.7mC$41.0mC$56.2mC$62.2m————
Shareholders' equityC$795.1mC$746.9mC$825.9mC$842.0mC$886.2mC$810.7mC$1.03bnC$991.2mC$979.7mC$642.1m
Shares outstanding101m107m115m125m132m140m143m143m121m97m

Cash flow

Fiscal years

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Cash from operationsC$36.3mC$35.9mC$45.0mC$44.6m−C$12.2mC$4.6m−C$5.7mC$23.5mC$14.7mC$7.6m
Capital spending−C$31.5m−C$10.0m−C$25.8m−C$224.2m−C$20.7m−C$3.0m−C$3.9m−C$130,000−C$9.9m−C$1.8m
Free cash flowC$4.8mC$26.0mC$19.2m−C$179.6m−C$32.9mC$1.6m−C$9.6mC$23.3mC$4.9mC$5.9m

Latest quarters

By quarter end

Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024Mar 2024Dec 2023
RevenueC$121.5mC$107.4mC$88.1mC$96.9mC$92.3mC$95.6mC$86.6mC$74.2m
Operating incomeC$646,000−C$3.7m−C$5.5m−C$3.0mC$3.2mC$2.4m−C$1.6m−C$83,000
Net income−C$3.8m−C$12.6mC$2.2mC$10.7mC$85,000−C$1.9m−C$4.5m−C$24.3m
Diluted earnings per share-0.04-0.130.020.110.00-0.02-0.04-0.23
Cash from operationsC$10.0mC$20.0mC$3.0mC$1.0mC$5.0m−C$1.0mC$30.0mC$17.0m
Capital spending−C$2.0m−C$25.0m−C$3.0m−C$1.0m−C$1.0m−C$17.0m−C$10.0m−C$1.0m
Free cash flowC$8.0m−C$5.0mC$0C$0C$4.0m−C$18.0mC$20.0mC$16.0m
Total assetsC$1.05bnC$1.04bnC$1.00bnC$963.8mC$962.3mC$945.4mC$968.2mC$945.5m
Cash and short-term investmentsC$118.1mC$112.6mC$160.0mC$163.1mC$172.3mC$157.5mC$192.1mC$157.8m
DebtC$84.7mC$82.5mC$29.7mC$29.3mC$36.5mC$38.6mC$48.0mC$49.5m
Shareholders' equityC$766.8mC$763.1mC$795.4mC$795.1mC$773.9mC$762.8mC$761.9mC$746.9m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue15.1%50.9%98.0%
Net income-34.9%-21.5%-28.6%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin2.0%-1.3%-3.2%-5.3%
Net margin-1.8%-2.2%2.0%16.5%

Valuation history

At each fiscal year end

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Price to earnings125.0-33.1-19.942.116.873.245.769.370.021.8
Price to sales1.51.72.02.73.522.488.2138.6220.8—

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.